AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Aminophylline In Sodium Chloride 0.45% In Plastic Container patents expire, and what generic alternatives are available?
Aminophylline In Sodium Chloride 0.45% In Plastic Container is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER is aminophylline. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aminophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aminophylline In Sodium Chloride 0.45% In Plastic Container
A generic version of AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER was approved as aminophylline by HOSPIRA on October 26th, 1983.
Summary for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Clinical Trials: | 36 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Medical College of Wisconsin | Phase 1/Phase 2 |
University of Oklahoma | Phase 1/Phase 2 |
Institute of Liver and Biliary Sciences, India | N/A |
See all AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER clinical trials